Profile
DNA Funded review: what are traders actually buying?
DNA Funded is a proprietary-trading-style evaluation provider operated under the name DNA Funded Ltd, incorporated in Saint Lucia. Its official terms describe simulated trading experiences: trades are representative and are not sent to a live market. Even its “Funded Stage” is a simulated programme with potential contractual payouts, not proof that a participant is trading a live portfolio of the stated account size. That distinction matters more than headline funding figures.
Assessment: DNA Funded publishes detailed rules, which is helpful for due diligence, but the cost of entry, account elimination rules, payout review discretion and restrictions make it unsuitable for anyone expecting a conventional regulated brokerage account or guaranteed income. The main website could not be independently opened during this check, so current acceptance of new orders and checkout prices remain unconfirmed. The amounts below are dated documentary terms, not verified live offers.
DNA Funded at a glance
| Question | Evidence-based answer |
|---|---|
| Provider and legal scope | DNA Funded Ltd; Saint Lucia company. Its published programme is simulated, not a live brokerage account. |
| Published challenge formats | One Phase, Two Phase, Rapid (10-day assessment) and Instant Funding; availability for new orders not independently confirmed. |
| Platform and markets | TradeLocker; simulated forex, indices, commodities, shares and cryptocurrencies. |
| Example access fee | Two Phase $50,000 nominal account: $289 before optional add-ons and applicable taxes, under the 23 February 2026 rules. |
| Baseline payout share | 80% of eligible simulated net profits; optional 90% split costs an additional 20% of the access fee. |
| Key payout restrictions | 14-day standard waiting period; $100 minimum; first three approved payouts subject to a 5%-of-nominal-bankroll profit cap. |
| Location information | A registered address is stated in a provider verification-policy document, but no comparable physical office address is verified for this directory listing. |
How the challenge models work
The official 23 February 2026 rules distinguish One Phase, Two Phase, Rapid and Instant Funding. One Phase requires one evaluation; Two Phase adds a verification stage; Rapid has a ten-day assessment window; Instant Funding bypasses evaluation but does not bypass funded-stage trading restrictions. “Instant” therefore refers to entry into a simulated funded stage, not a transfer of real capital to the trader.
For accounts opened on or after 3 February 2026, the published Two Phase model has an 8% first-stage profit target and a 5% second-stage target, with a 5% maximum daily drawdown and an 8% static maximum drawdown. The One Phase model has a 10% target, 4% daily loss limit and 6% maximum loss. Rapid has a 5% target, 3% daily loss limit and 5% maximum loss. Rules for older accounts differ, so traders should not assume a rule from an earlier purchase applies to a new one.
What a $50,000 Two Phase account actually means
The February schedule prices the $50,000 nominal Two Phase challenge at $289 before taxes and add-ons. An 8% first-stage simulated target is $4,000 and the subsequent 5% target is $2,500. A 5% daily loss limit represents $2,500 against a $50,000 reference balance; the actual calculation uses the previous day’s balance snapshot. The 8% overall limit represents $4,000 against the initial nominal balance. These figures are illustrative rule arithmetic, not money deposited into a trader’s account or an earnings forecast.
A 90% profit-share add-on priced at 20% of the initial fee would increase that example’s entry cost from $289 to $346.80, excluding taxes. The higher share has no value unless the trader first becomes payout-eligible and the firm approves payment. The separate early-payout add-on is also priced at 20% of the initial fee; buyers should check how selected extras combine at checkout.
Payouts: important limitations beyond the headline split
The baseline published share is 80%, with a $100 minimum payout and a standard 14-day waiting period. The first three approved payouts are subject to a profit cap of 5% of nominal account size; excess profit above the cap can be forfeited when the account resets. For accounts opened on or after 3 February 2026, the daily profit-distribution rule limits any single day’s contribution to 30% of the requested profit; older accounts may use 40%. This means a single unusually profitable day cannot by itself support a large qualifying payout.
The firm’s Risk team retains extensive discretion to assess and approve requests. It may require identity verification and a call; a failure to comply can delay or prevent payment. Its published processing estimate is not a guarantee. A payout should never be treated as earned cash until the relevant conditions have been met and payment received.
Trading costs, platforms and restrictions
The February document identifies TradeLocker as the platform and specifies simulated markets including forex, commodities, indices, cryptocurrencies and shares. It lists crypto commission of 0.01% of notional volume on opening; US shares at $2 per lot on opening and closing; non-US shares at 0.1% of notional volume on opening and closing; and other instruments at $5 per lot on opening. It also refers to standard swaps. Spread and financing costs can therefore matter alongside the one-off access fee; live spreads and platform availability were not independently tested.
Prohibited behaviours include high-frequency trading and hedging as defined in the rules. Funded-stage restrictions additionally cover certain very short scalps, martingale and grid methods. Account sharing and some copy-trading behaviours are restricted. A strategy that works in a normal demo or brokerage account may still breach these contractual rules, so traders using automation, correlation hedges or news strategies need to inspect the complete prohibited-acts schedule before paying.
Legal entity, regulation and UK consumer protection
DNA Funded’s general terms name DNA Funded Ltd and select Saint Lucia law. Its official participant-verification policy identifies registration number 2025-00574. These are provider-published identity statements; the underlying Saint Lucia company-register entry was not independently obtained in this review. Incorporation is not the same as financial-services authorisation. No FCA authorisation or FSCS coverage has been established for the simulated programme. UK readers should not assume deposit protection, investment compensation or broker client-money safeguards apply.
The published rules exclude citizens or residents of several jurisdictions, including Australia and Saint Lucia, with a limited stated residency-discretion provision. Eligibility must be checked against current terms and the actual contracting entity. This review does not certify that every country not on that list is accepted.
Strengths, limitations and who it may suit
Potential advantages: relatively detailed publicly available rules; a choice of assessment structures; stated nominal account sizes; and clearly described numerical drawdown and payout restrictions. These are documentary features, not independently tested service quality.
Important disadvantages: upfront fees can be lost, simulated profits are not freely withdrawable, funded-stage behaviour is heavily restricted, and payout approval is discretionary. The 30% daily contribution rule and first-three-payout profit cap can materially change the economics of a seemingly attractive profit split. Current ordering status, present prices, customer support responsiveness and actual payment outcomes were not independently verified.
This structure may be relevant to experienced traders who understand simulated evaluations, can absorb the full loss of the participation fee and can trade consistently within tightly defined limits. It is a poor fit for people seeking a regulated investment account, access to their own deposited funds, unrestricted strategy execution or dependable wages.
Questions to resolve before paying
Is DNA Funded live trading?
Its published rules say no: the simulated trading experience does not place the participant’s trades in the live market, including at the funded stage.
Is the advertised account size withdrawable?
No. It is a nominal simulated bankroll for calculating performance and risk rules, not a cash balance owned by the trader.
Does a 90% profit split come as standard?
No. The February terms specify 80% as standard and a paid add-on for 90%, subject to payout eligibility and approval.
Can one profitable day qualify for a full payout?
Not under the published daily contribution rule for newer accounts: one day may contribute no more than 30% of the requested qualifying profit.
Are new accounts currently available?
Not independently confirmed on 17 November 2026. The provider homepage was inaccessible to this review and third-party reports have noted pauses in new orders. Verify availability and current terms directly before attempting payment.
Conclusion
DNA Funded should be evaluated as a fee-based simulated trading programme with contractual payout eligibility, not as a broker providing live funded investment accounts. Its published terms offer enough detail to calculate risk limits, but current order availability, independent payment outcomes and some legal-register details remain unverified. Review the actual purchase agreement, rule version, eligibility and payout conditions before committing money.
Sources and verification
Documentary review performed 17 November 2026. Provider documents are primary evidence of stated contractual terms, not independent evidence that payouts occur or the service is currently operational.
- DNA Funded: Rules and Conditions, version dated 23 February 2026
- DNA Funded: General Terms and Conditions, January 2026
- DNA Funded: Participant Verification Policy, provider-published registration details
Independent editorial information, not investment advice or an endorsement. No trading or payout tests were conducted.
November 2026 availability note
Update checked 18 November 2026: A recently updated third-party summary reports that DNA Funded has paused new challenge orders. Because this has not been independently confirmed through a live provider checkout, the availability of new accounts should be treated as unconfirmed. Do not assume that historic published fees are current or that an evaluation can presently be purchased. Check the official provider website and current terms before attempting payment.
The provider’s January 2026 Rules and Conditions version 2 also describes a temporary 5% profit cap for the first three approved payouts and restrictions on certain trading strategies, including hedging and high-frequency trading. These are provider-published contractual rules, not evidence of successful payouts. See DNA Funded Rules and Conditions V2 (29 January 2026). Product rules may change.
Contractual payout checks: what the general terms actually say
Additional primary-source check, 22 November 2026: DNA Funded’s General Terms and Conditions, version 2.0, section 13, characterise payouts as discretionary performance rewards for simulated trading participation, not investment returns, employment wages or brokerage withdrawals. Section 13.3 expressly states that participation does not guarantee a payout. Sections 13.4–13.8 require compliance with applicable trading conditions and identity-verification checks; the provider can review trading activity and withhold or decline a reward where conditions are not met. These restrictions materially affect the meaning of any advertised profit split.
The older published rules, version 1 dated 4 July 2025, state an 80% standard share, a US$100 minimum reward, a 14-day waiting period, a 40% daily contribution limit and a 5% cap for the first three approved payouts. Do not assume these older figures apply to new purchases: later contractual revisions and account-specific terms may supersede them. Where the provider’s current ordering status, product rules or live checkout cannot be independently established, the correct conclusion is that the present commercial terms are unconfirmed, not that historical offers remain available.

